Citigroup’s EMULEX CORP ELX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-12,000
Closed -$96K 8094
2015
Q1
$96K Buy
12,000
+1,500
+14% +$10.5K ﹤0.01% 5061
2014
Q4
$60K Buy
10,500
+1,300
+14% +$7.01K ﹤0.01% 5577
2014
Q3
$45K Sell
9,200
-8,000
-47% -$43.3K ﹤0.01% 5383
2014
Q2
$98K Sell
17,200
-17,500
-50% -$104K ﹤0.01% 4688
2014
Q1
$256K Buy
34,700
+3,400
+11% +$25K ﹤0.01% 4105
2013
Q4
$224K Sell
31,300
-5,900
-16% -$43.8K ﹤0.01% 4559
2013
Q3
$289K Buy
37,200
+3,600
+11% +$28K ﹤0.01% 3860
2013
Q2
$219K Buy
+33,600
New +$211K ﹤0.01% 4203

Citigroup's ELX Position: Q2 2015 in Review

Citigroup sold out of EMULEX CORP (ELX) in Q2 2015, closing a stake of 59,032 shares — an estimated $471K sold.

Citigroup first reported a position in ELX in Q2 2013 and held it in 8 quarters. The position peaked at $1.09M in Q4 2014. 0 funds tracked by Wall St. Rank hold ELX as of Q2 2015.

  • Citigroup reported no remaining EMULEX CORP position as of Q2 2015 after selling out during the quarter.
  • Citigroup sold 59,032 EMULEX CORP shares in Q2 2015, an estimated $471K.
  • Citigroup first reported a position in EMULEX CORP in Q2 2013 and held it in 8 quarters.
  • Citigroup's EMULEX CORP position peaked at $1.09M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held EMULEX CORP as of Q2 2015.

Based on Citigroup's 13F filing for Q2 2015, filed 13 Aug 2015.